Table 1.
Variables | miR-144-5 pexpression level | P-value | miR-451a expression level | P-value | |||
---|---|---|---|---|---|---|---|
Low | High | Low | High | ||||
Gender | Male | 33 | 23 | 0.115 | 29 | 27 | 0.445 |
Female | 18 | 24 | 25 | 17 | |||
Age(y) | <60 | 28 | 21 | 0.419 | 28 | 21 | 0.839 |
≥60 | 23 | 26 | 26 | 23 | |||
ALB(U/L) | <28 | 2 | 2 | 0.917 | 3 | 1 | 0.269 |
28–35 | 8 | 6 | 0.917 | 10 | 4 | 0.255 | |
>35 | 41 | 39 | 0.826 | 41 | 39 | 0.121 | |
HBsAg | No | 21 | 33 | 0.005 | 24 | 30 | 0.025 |
Yes | 30 | 14 | 30 | 14 | |||
HCVAg | No | 49 | 46 | 1.000 | 51 | 44 | 0.250 |
Yes | 2 | 1 | 3 | 0 | |||
Tumor number |
Single | 25 | 30 | 0.158 | 24 | 31 | 0.014 |
Multiple | 26 | 17 | 30 | 13 | |||
Tumor size | <5cm | 15 | 27 | 0.008 | 15 | 27 | 0.001 |
≥5cm | 36 | 20 | 39 | 17 | |||
TNM stage | I–III | 40 | 41 | 0.294 | 48 | 33 | 0.107 |
IV | 11 | 6 | 6 | 11 | |||
Vascular invasion |
No | 22 | 30 | 0.046 | 22 | 30 | 0.008 |
Yes | 29 | 17 | 32 | 14 | |||
LN metastasis |
No | 32 | 30 | 1.000 | 37 | 25 | 0.293 |
Yes | 19 | 17 | 17 | 19 |
The chi-square tests were adopted to analyze correlation between miR-144-5p or miR-451a levels and clinicopathological features in cholangiocarcinoma. The mean value of expression level was used as the cutoff. Bold values had statistical significance. intrahepatic cholangiocarcinoma=84, perihilar cholangiocarcinoma=14.